AGU
- NYSE - CHEMICALS - Agricultural Chemicals
Agrium Inc
|
$93.74 |
-0.45 -0.48%
|
$96.33
|
$97.64
|
-3.99% |
1,014,787 97.28%
|
1,043,200
|
Most Recent Note for AGU - 8/3/2012 11:52:39 AM
Consolidating above prior resistance in the $89 area. Reported earnings +20% on +10% sales for the Jun '12 quarter. The 7/03/12 mid-day report noted - "It faces additional overhead supply. It survived but failed to impress since noted in the 2/09/11 mid-day report - 'Recent quarters showed improving sales and earnings but its prior history is below guidelines of the fact-based investment system. Based on weak technical action it was dropped from the Featured Stocks list 7/25/08, and it subsequently dropped from $84.18 to $22.08 before rebounding.'"
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AIRM
- NASDAQ - TRANSPORTATION - Air Services, Other
Air Methods Corp
|
$114.00 |
+5.43
5.00%
|
$116.75
|
$116.75
|
-2.36% |
89,574 76.69%
|
116,800
|
Most Recent Note for AIRM - 8/3/2012 11:55:10 AM
Gapped up today hitting another new 52-week high, clearing its high hit when last noted in the 7/18/12 mid-day report while gapping up for a considerable volume-driven gain. Earnings and sales revenues improved greatly in the Mar '12 and Jun '12 quarters following sub par results in the Sep and Dec '11 comparisons. Prior mid-day reports noted - "Sales and earnings growth history has been erratic and below guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AWR
- NYSE - UTILITIES - Water Utilities
American States Water
|
$41.11 |
+0.56
1.38%
|
$41.20
|
$41.72
|
-1.46% |
86,297 94.42%
|
91,400
|
Most Recent Note for AWR - 8/3/2012 11:59:06 AM
Consolidating in a tight range near its 52-week high since last noted in the 7/12/12 mid-day report - "This Utility - Water Supply firm's annual earnings history (A criteria) is not a match with the fundamental guidelines of the fact-based system, however 3 of the past 4 quarterly comparisons through Mar '12 showed earnings increases above the +25% guideline."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CF
- NYSE - CHEMICALS - Agricultural Chemicals
C F Industries Holdings
|
$204.95 |
+10.56
5.43%
|
$205.00
|
$208.43
|
-1.67% |
1,041,822 76.53%
|
1,361,300
|
Most Recent Note for CF - 8/3/2012 12:04:20 PM
Gapped up today, rallying near its 52-week high, and no resistance remains due to overhead supply. Due to report Q2 earnings on Monday, August 6th. Rebounded after a choppy consolidation below its 200 DMA line since noted in the 4/25/12 mid-day report - "This high-ranked leader's earnings and sales revenues showed great increases in recent quarterly comparisons, however it lacks a good steady annual earnings growth history (the A criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DWCH
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Business Software & Services
Datawatch Corp
|
$16.52 |
-0.08 -0.46%
|
$16.80
|
$16.80
|
-1.65% |
21,288 99.94%
|
21,300
|
Most Recent Note for DWCH - 8/3/2012 12:10:40 PM
Holding its ground stubbornly and rising into new high territory since its considerable volume-driven gain on 7/27/12 for a new 52-week high. Strong sales and earnings increases in the 3 latest quarterly comparisons through Jun '12 satisfy the C criteria, but its annual earnings (A criteria) history is not a match with the fact-based system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FEIC
- NASDAQ - ELECTRONICS - Diversified Electronics
F E I Co
|
$51.88 |
+5.20
11.14%
|
$52.52
|
$52.52
|
-1.22% |
578,449 180.71%
|
320,100
|
Most Recent Note for FEIC - 8/3/2012 12:21:58 PM
Found support above its 200 DMA line in recent months and it hit a new 52-week high with today's considerable volume-driven gain. Weak action and deteriorating fundamentals prompted it to be dropped from the Featured Stocks list on 5/15/12. Reported earnings +19% on +5% sales revenues for the quarter ended June 30, 2012 versus the year ago period, marking 3 consecutive quarters below the +25% minimum guideline for earnings growth.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
G
- NYSE - DIVERSIFIED SERVICES - Business/Management Services
Genpact Ltd
|
$19.08 |
+0.56
3.02%
|
$19.52
|
$19.52
|
-2.25% |
658,673 126.11%
|
522,300
|
Most Recent Note for G - 8/3/2012 12:28:00 PM
Hitting new 52-week and all-time highs with a 2nd consecutive volume-driven gain, quickly getting extended from prior highs in the $17 area. Three of the past 4 quarterly comparisons through Jun '12 showed earnings increases above the +25% guideline (C criteria). Its annual earnings were virtually flat from FY '08 to FY '10, not strong and steady as the A criteria suggests.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IPXL
- NASDAQ - DRUGS - Drugs - Generic
Impax Laboratories Inc
|
$23.10 |
+0.46
2.03%
|
$23.32
|
$25.36
|
-8.91% |
489,914 96.88%
|
505,700
|
Most Recent Note for IPXL - 8/3/2012 12:32:12 PM
Recent quarters through Jun '12 show strong sales and earnings increases satisfying the C criteria. Its annual earnings (A criteria) history has been erratic not a match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IT
- NYSE - DIVERSIFIED SERVICES - Business/Management Services
Gartner Inc
|
$46.63 |
+2.09
4.69%
|
$48.51
|
$48.51
|
-3.88% |
495,469 90.07%
|
550,100
|
Most Recent Note for IT - 8/3/2012 12:35:50 PM
Gapped up today and hit new 52-week and all-time highs. Found support near its 50 DMA line recently. Reported earnings +32% on +9% sales revenues for the quarter ended June 30 2012 versus the year ago period. The 2 prior quarterly comparisons had earnings increasing below the +25% minimum guideline, and a downward turn in FY '09 earnings raises concerns with respect to the C and A criteria of the fact-based system's guidelines. It survived and rebounded in recent years after deteriorating badly after it was dropped from the Featured Stocks list on 10/02/08.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MCC
- NYSE - MATERIALS & CONSTRUCTION - General Building Materials
Medley Capital Corp
|
$12.76 |
+0.52
4.25%
|
$12.81
|
$12.81
|
-0.39% |
261,536 196.20%
|
133,300
|
Most Recent Note for MCC - 8/3/2012 12:38:04 PM
Gapped up today and rallied for new 52-week and all-time highs. The 7/30/12 mid-day report noted - "Earnings history is not a match with the winning models of the fact-based system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MDAS
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Healthcare Information Service
Medassets Inc
|
$15.81 |
+0.40
2.60%
|
$15.99
|
$16.00
|
-1.19% |
652,280 151.13%
|
431,600
|
Most Recent Note for MDAS - 8/3/2012 12:39:10 PM
Holding its ground today after a considerable gap up and volume-driven gain for a new 52-week high on the prior session. Reported earnings +22% on +11% sales revenues for the Jun '12 quarter, below the +25% guidelines, raising fundamental concerns.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$156.12 |
+4.12
2.71%
|
$156.20
|
$156.32
|
-0.13% |
365,604 96.21%
|
380,000
|
Most Recent Note for NVO - 8/3/2012 12:40:38 PM
Today's gain has it rallying into new all-time high territory. Its 3 latest quarterly comparisons through Mar '12 had earnings increases below the +25% guideline (not meeting the C criteria). It went through a deep consolidation below its 200 DMA line then rebounded since noted in the 7/28/11 mid-day report. - "It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. This Denmark-based Medical - Ethical Drug firm also has seen the number of top-rated funds owning its shares rise from 152 in Mar '10 to 204 in Mar '11, a reassuring sign concerning the I criteria."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SXL
- NYSE - ENERGY - Oil & Gas Pipelines
Sunoco Logistics Ptnr Lp
|
$43.17 |
+3.06
7.63%
|
$43.51
|
$43.51
|
-0.78% |
225,786 127.13%
|
177,600
|
Most Recent Note for SXL - 8/3/2012 12:44:14 PM
This MLP gapped up today for a considerable gain and it is hitting a new 52-week high. Reported earnings +60% on +37% sales revenues for the quarter ended June 30, 2012 versus the year ago period. Its shares split 3:1 on 12/05/11. Earnings increases in recent quarterly comparisons satisfy the C criteria, but its up and down annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TRIB
- NASDAQ - DRUGS - Diagnostic Substances
Trinity Biotech Plc Adr
|
$12.73 |
+0.14
1.11%
|
$12.75
|
$12.76
|
-0.24% |
41,486 75.70%
|
54,800
|
Most Recent Note for TRIB - 8/3/2012 12:44:46 PM
Still hovering near its 52-week high today. Reported earnings +12% on +7% sales revenues for the quarter ended June 30, 2012 versus the year ago period. Volume totals have been cooling after a recent spurt of gains with above average volume helped it make progress above its prior highs. Held its ground stubbornly while several mid-day reports since May repeatedly noted - "Consolidating above prior highs and its 50 DMA line in the $11 area that define chart support. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Annual earnings (A criteria) showed steady increases since a downturn in FY '08. This Ireland-based firm hailing from the Medical - Products industry group is not a match with the winning models from the book, 'How To Make Money In Stocks'. The past 8 quarterly earnings comparisons through Mar '12 were below the +25% minimum guideline of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TWC
- NYSE - MEDIA - CATV Systems
Time Warner Cable Inc
|
$89.90 |
+1.96
2.22%
|
$89.99
|
$89.99
|
-0.11% |
1,514,091 87.06%
|
1,739,200
|
Most Recent Note for TWC - 8/3/2012 12:45:17 PM
Hitting new 52-week and all-time highs again today with a 3rd consecutive volume-driven gain. Reported earnings +23% on +9% sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day reports noted - "Its quarterly and annual earnings history has not been a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VASC
- NASDAQ - HEALTH SERVICES - Medical Instruments & Supplies
Vascular Solutions
|
$13.85 |
+0.40
2.94%
|
$13.85
|
$13.85
|
-0.04% |
77,136 141.53%
|
54,500
|
Most Recent Note for VASC - 8/3/2012 12:46:35 PM
Matched its 52-week high today while adding another volume-driven gain to its recent spurt. The 7/25/12 mid-day report noted - "Fundamentals are still not a match with the fact-based investment system's guidelines. Reported earnings +15% on +11% sales revenues for the Jun '12 quarter. Survived but failed to impress since noted in the 8/08/11 mid-day report - 'Gapped down today, pulling back from its 52-week high hit last week. Annual earnings (A criteria) history has been good. The 2 latest quarterly comparisons versus the year ago period showed sales revenues increases in the +14-17% range with earnings per share increases in the +25-44% range. Ownership by top-rated funds fell from 124 in Dec '10 to 116 in Jun '11, whereas increasing institutional interest (I criteria) is clearly desired.'"
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|